Gapping down
In reaction to earnings/guidance:
- CRWD -18%, NTAP -10.8%, LESL -7.6%, HRL -5.5%, SDRL -2%
Other news:
- XFOR -14.6% (top-line results from phase 3 trial of Oral Mavorixafor)
- ASPN -11.8% (prices offering of 25263158 shares of its common stock at $9.50 per share)
- ASTS -9.3% (prices upsized $75000000 public offering of Class A common stock)
- SLDP -8.6% (CEO to retire)
- MU -0.9% (makes cautious comments on pricing at investor conference)